Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Ovalle: Effect of rosiglitazone versus insulin on the pancreatic β-cell function of subjects.... (0.13 sec) 

Effect of rosiglitazone versus insulin on the pancreatic β-cell function of subjects with Type 2 …

- Free from Publisher
F Ovalle, DSH Bell - Diabetes care, 2004 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A total of 17 subjects with type 2 diabetes,
inadequately controlled on a maximized oral antihyperglycemic double regimen of
glimepiride and metformin, were randomized to the addition of rosiglitazone ...
Cited by 63 - Related articles - BL Direct - All 9 versions

[PDF] METODIKOS, REKOMENDACIJOSIRALGORITMAI


C DIABETO - Šiame numeryje skaitykite - e-library.lt
GYDYMO MENAS & Medicina Nr. 04 (116) 2005 m. I. CUKRINIO DIABETO DIAGNOSTIKA l.
Cukrinio diabeto diagnozė nustatoma: 1.1. pagal hiperglikemijos lygį; 1.2.
atlikus gliukozės tolerancijos mėgi- nį (toliau–GTM), nes tai yra ...
Related articles - View as HTML

Long-term glycaemic efficacy and weight changes associated with thiazolidinediones when …


DS Bell, F Ovalle - Diabetes Obesity and Metabolism, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 16 - Related articles - BL Direct - All 4 versions

Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin: insulin …

- endojournals.org
SA Smith, LE Porter, N Biswas, MI Freed - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc
An elevation in the ratio of proinsulin (PI) to immunoreactive insulin (IRI) is
inversely related to ß-cell function in type 2 diabetes, and increased PI is an
independent risk factor for coronary heart disease. An objective of the ...
Cited by 38 - Related articles - All 5 versions

β-cell rejuvenation with thiazolidinediones


DSH Bell - The American journal of medicine, 2003 - Elsevier
Type 2 diabetes mellitus manifests in an insulin-resistant individual when
pancreatic β-cells are unable to produce sufficient insulin to overcome insulin
resistance in the muscles and liver. There is a growing body of evidence ...
Cited by 51 - Related articles - All 8 versions

Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function …


F Ovalle, DSH Bell - Diabetes Obesity and Metabolism, 2002 - interscience.wiley.com
Patients and Methods:This is an observational, nested case‐control study. We
identified 28 patients (TZD group), with T2DM, who had had a meal‐stimulated
C‐peptide level documented before the addition of troglitazone to a ...
Cited by 85 - Related articles - BL Direct - All 3 versions

Rosiglitazone prevents the impairment of human islet function induced by fatty acids: …

- physiology.org
R Lupi, S Del Guerra, L Marselli, M Bugliani, … - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc
Peroxisome proliferator-activated receptors (PPARs) are a subgroup of the
superfamily of nuclear receptors, with three distinct main types: , and
(subdivided into 1 and 2 ). Recently, the presence of PPAR has been ...
Cited by 78 - Related articles - BL Direct - All 4 versions

Pioglitazone preserves pancreatic islet structure and insulin secretory function in three …

- physiology.org
AR Diani, G Sawada, B Wyse, FT Murray, M … - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc
Thiazolidinediones may slow the progression of type 2 diabetes by preserving
pancreatic -cells. The effects of pioglitazone (PIO) on structure and function
of -cells in KKA(y), C57BL/6J ob/ob, and C57BL/KsJ db/db mice (genetic ...
Cited by 57 - Related articles - BL Direct - All 4 versions

Long-term efficacy of triple oral therapy for type 2 diabetes mellitus


DSH Bell, F Ovalle - Endocrine Practice, 2002 - AACE
Before 1995 in the United States, only insulin and sul- fonylureas were
available for treatment of type 2 diabetes. When sulfonylureas failed to provide
glycemic control, insulin either was added to or replaced sulfonylurea ...
Cited by 49 - Related articles - BL Direct - All 2 versions

Influence of Rosiglitazone Treatment on {beta}-Cell Function in Type 2 Diabetes: Evidence of …

- endojournals.org
CB Juhl, M Hollingdal, N Porksen, A Prange, … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc
Thiazolidinediones have well-established insulin-sensitizing effects. Their
impact on insulin secretion is less clarified. Consequently, we sought to
determine potential effects of a thiazolidinedione (rosiglitazone) on the ...
Cited by 53 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google